Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 1/2 1

Status

Completed 5Unknown 3Recruiting 3Terminated 2Not yet recruiting 1

Sponsor Class

INDUSTRY 5

Study Type

Interventional 5

Sponsor

Conditions

Neoplasms 1331Breast Neoplasms 688Carcinoma, Non-Small-Cell Lung 543Neoplasm Metastasis 437Lymphoma 435Leukemia, Myeloid, Acute 432Melanoma 402Prostatic Neoplasms 380Multiple Myeloma 366Lymphoma, Non-Hodgkin 356Ovarian Neoplasms 343Colorectal Neoplasms 333Precursor Cell Lymphoblastic Leukemia-Lymphoma 328Pancreatic Neoplasms 328Leukemia, Lymphocytic, Chronic, B-Cell 323Leukemia 282Lung Neoplasms 275Glioblastoma 267Unspecified Adult Solid Tumor, Protocol Specific 257Recurrence 254Lymphoma, Follicular 248Lymphoma, Large B-Cell, Diffuse 245Brain Neoplasms 232Lymphoma, Mantle-Cell 210Hodgkin Disease 193Carcinoma, Renal Cell 193Head and Neck Neoplasms 192Myelodysplastic Syndromes 187Glioma 172Burkitt Lymphoma 172

Interventions

Radiotherapy 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Completed × Advanced Tumors × Clear all
NCT03444714 2025-09-15

Phase I Study of RiMO-301 With Radiation in Advanced Tumors

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
32 enrolled

Advanced Tumors

NCT05429008 2025-06-18

A Phase I Clinical Study of HMPL-A83 in Patients With Advanced Malignant Neoplasm

Hutchmed

Phase 1 Completed
40 enrolled

Advanced Tumors

NCT04151810 2024-08-27

Phase I Clinical Trial of CDP1 in Patients With Advanced Solid Tumors

Dragonboat Biopharmaceutical Company Limited

Phase 1 Completed
32 enrolled

Advanced Tumors

NCT04808453 2024-02-07

CPI-300

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
17 enrolled

Advanced Tumors

NCT03781362 2022-07-20

Study of CPI-100 in Patients With Advanced Tumors

Coordination Pharmaceuticals, Inc.

Phase 1 Completed
36 enrolled

Advanced Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡